ABVC BioPharma, Inc. Income (Loss) from Equity Method Investments
ABVC BioPharma, Inc. (ABVC) reported Income (Loss) from Equity Method Investments of -$24.77 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-12
- ABVC BioPharma, Inc. income (loss) from equity method investments for the quarter ending 2026-06-30 was -$24.77K.
- ABVC BioPharma, Inc. income (loss) from equity method investments for the quarter ending 2026-03-31 was -$31.42K.
- ABVC BioPharma, Inc. income (loss) from equity method investments for the quarter ending 2025-12-31 was -$652.98K.
- ABVC BioPharma, Inc. income (loss) from equity method investments for the quarter ending 2025-09-30 was -$54.23K.
- ABVC BioPharma, Inc. income (loss) from equity method investments for fiscal 2025 was -$803.01K.
- ABVC BioPharma, Inc. income (loss) from equity method investments for fiscal 2023 was -$221.89K.
- ABVC BioPharma, Inc. income (loss) from equity method investments for fiscal 2021 was -$269.84K.
- ABVC BioPharma, Inc. income (loss) from equity method investments for fiscal 2019 was -$210.09K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 6 month as first filed | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$24.77K 10-Q · filed 2026-08-12 | -$56.18K 10-Q · filed 2026-08-12 | -$709.16K derived: sum of 3 quarters · filed 2026-08-12 | -$763.40K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$31.42K 10-Q · filed 2026-05-18 | -$684.39K derived: sum of 2 quarters · filed 2026-05-18 | -$738.63K derived: sum of 3 quarters · filed 2026-05-18 | -$783.55K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | -$652.98K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | -$707.21K derived: sum of 2 quarters · filed 2026-03-03 | -$752.13K derived: sum of 3 quarters · filed 2026-08-12 | -$803.01K 10-K · filed 2026-03-03 | ||
| 2025-09-30 | -$54.23K 10-Q/A · filed 2026-03-03 | -$99.15K derived: sum of 2 quarters · filed 2026-08-12 | -$150.03K 10-Q/A · filed 2026-03-03 | |||
| 2025-06-30 | -$44.92K 10-Q · filed 2026-08-12 | -$95.79K 10-Q · filed 2026-08-12 | ||||
| 2025-03-31 | -$50.88K 10-Q · filed 2026-05-18 | |||||
| 2024-09-30 | -$67.89K 10-Q/A · filed 2026-03-03 | -$146.94K derived: sum of 2 quarters · filed 2026-03-03 | -$146.94K 10-Q/A · filed 2026-03-03 | |||
| 2024-06-30 | -$79.06K 10-Q · filed 2025-08-13 | -$79.06K 10-Q · filed 2025-08-13 | $79.06K 10-Q · filed 2024-08-14 | |||
| 2023-12-31 | -$221.89K 10-K · filed 2024-03-13 | |||||
| 2021-12-31 | -$269.84K 10-K · filed 2023-03-31 | |||||
| 2019-12-31 | -$27.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | -$92.66K derived: sum of 2 quarters · filed 2020-05-15 | -$143.88K derived: sum of 3 quarters · filed 2020-05-15 | -$210.09K 10-K · filed 2020-05-15 | ||
| 2019-09-30 | -$64.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-18 | -$115.91K derived: sum of 2 quarters · filed 2019-11-18 | -$182.11K 10-Q · filed 2019-11-18 | -$210.48K derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2019-06-30 | -$51.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$117.42K 10-Q · filed 2019-08-09 | -$145.79K derived: sum of 3 quarters · filed 2020-05-15 | -$184.95K derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2019-03-31 | -$66.20K 10-Q · filed 2019-05-28 | -$94.57K derived: sum of 2 quarters · filed 2020-05-15 | -$133.73K derived: sum of 3 quarters · filed 2020-05-15 | -$220.65K derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | -$28.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | -$67.53K derived: sum of 2 quarters · filed 2020-05-15 | -$154.44K derived: sum of 3 quarters · filed 2020-05-15 | -$193.01K 10-K · filed 2020-05-15 | -$2.55M 10-K · filed 2019-04-15 | |
| 2018-09-30 | -$39.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-18 | -$126.08K derived: sum of 2 quarters · filed 2019-11-18 | -$164.65K 10-Q · filed 2019-11-18 | |||
| 2018-06-30 | -$86.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$125.48K 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | -$38.57K 10-Q · filed 2019-05-28 |